Role of Ubiquitin-conjugating enzyme E2 (UBE2) in two immune-mediated inflammatory skin diseases: a mendelian randomization analysis
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-02976-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Xiaoxue Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Genetic Predisposition to Disease, Genome-Wide Association Study, Mendelian Randomization Analysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shaanxi Province, Youth Fund of the Second Affiliated Hospital of Xi'an Jiaotong University, Youth Fund of the Second Affiliated Hospital of Xi’an Jiaotong University.
Abstract (Originalsprache)
Psoriasis vulgaris (PV) and Atopic dermatitis (AD) are the two major types of immune-mediated inflammatory skin disease (IMISD). Limited studies reported the association between Ubiquitin-conjugating enzyme E2 (UBE2) and IMISD. We employed a two-sample Mendelian randomization (MR) study to assess the causality between UBE2 and PV & AD. UBE2 association genome-wide association study (GWAS) data were collected. The inverse variance weighted (IVW) method was utilized as the principal method in our Mendelian randomization (MR) study, with additional using the MR-Egger, weighted median, simple mode, and weighted mode methods. The MR-Egger intercept test, Cochran’s Q test, MR-Pleiotropy RESidual Sum and Outlier (MR-PRESSO) and leave-one-out analysis were conducted to identify heterogeneity and pleiotropy, colocalization analysis was also performed. The results showed that Ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1) was causally associated with PV (OR = 0.909, 95% CI: 0.830–0.996, P = 0.040), Ubiquitin-conjugating enzyme E2 L3 (UBE2L3) was causally associated with AD (OR = 0.799, 95% CI: 0.709–0.990, P < 0.001). Both UBE2V1 and UBE2L3 may play protective roles in patients with PV or AD, respectively. No other significant result has been investigated. No heterogeneity or pleiotropy was observed. This study provided new evidence of the relationship between UBE2V1 and PV, UBE2L3 and AD. Our MR suggested that UBE2V1 plays an inhibitory role in PV progression, UBE2L3 plays an inhibitory role in AD. These could be novel and effective ways to treat PV and AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Surgical Oncology, The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. zhuzexinmd@163.com.
Förderung
- Natural Science Foundation of Shaanxi Province
- Youth Fund of the Second Affiliated Hospital of Xi'an Jiaotong University
- Youth Fund of the Second Affiliated Hospital of Xi’an Jiaotong University
Zitieren
APA
Wang, X., & Zhu, Z. (2024). Role of Ubiquitin-conjugating enzyme E2 (UBE2) in two immune-mediated inflammatory skin diseases: a mendelian randomization analysis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-02976-4
Vancouver
Wang X, Zhu Z. Role of Ubiquitin-conjugating enzyme E2 (UBE2) in two immune-mediated inflammatory skin diseases: a mendelian randomization analysis. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-02976-4
BibTeX
@article{Wang2024,
author = {Wang, Xiaoxue and Zhu, Zexin},
title = {Role of Ubiquitin-conjugating enzyme E2 (UBE2) in two immune-mediated inflammatory skin diseases: a mendelian randomization analysis},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-02976-4}
}
EUVIMED